African Population and Health Research Center, P.O. Box 10787-00100, GPO Nairobi, Kenya.
BMC Public Health. 2013 Jun 17;13:588. doi: 10.1186/1471-2458-13-588.
It has been almost a decade since HIV was declared a national disaster in Kenya. Antiretroviral therapy (ART) provision has been a mainstay of HIV treatment efforts globally. In Kenya, the government started ART provision in 2003 with significantly scale-up after 2006. This study aims to demonstrate changes in population-level HIV mortality in two high HIV prevalence slums in Nairobi with respect to the initiation and subsequent scale-up of the national ART program.
We used data from 2070 deaths of people aged 15-54 years that occurred between 2003 and 2010 in a population of about 72,000 individuals living in two slums covered by the Nairobi Urban Health and Demographic Surveillance System. Only deaths for which verbal autopsy was conducted were included in the study. We divided the analysis into two time periods: the "early" period (2003-2006) which coincides with the initiation of ART program in Kenya, and the "late" period (2007-2010) which coincides with the scale up of the program nationally. We calculated the mortality rate per 1000 person years by gender and age for both periods. Poisson regression was used to predict the risk of HIV mortality in the two periods while controlling for age and gender.
Overall, HIV mortality declined significantly from 2.5 per 1,000 person years in the early period to 1.7 per 1,000 person years in the late period. The risk of dying from HIV was 53 percent less in the late period compared to the period before, controlling for age and gender. Women experienced a decline in HIV mortality between the two periods that was more than double that of men. At the same time, the risk of non-HIV mortality did not change significantly between the two time periods.
Population-level HIV mortality in Nairobi's slums was significantly lower in the approximate period coinciding with the scale-up of ART provision in Kenya. However, further studies that incorporate ART coverage data in mortality estimates are needed. Such information will enhance our understanding of the full impact of ART scale-up in reducing adult mortality among marginalized slum populations in Kenya.
自 2003 年在肯尼亚宣布艾滋病为全国性灾难以来,已经过去了近十年。抗逆转录病毒疗法(ART)的提供一直是全球艾滋病治疗工作的主要支柱。在肯尼亚,政府于 2003 年开始提供 ART,并在 2006 年后大幅扩大规模。本研究旨在展示在国家 ART 项目启动和随后扩大规模的情况下,内罗毕两个高 HIV 流行率贫民区的人群 HIV 死亡率的变化。
我们使用了 2003 年至 2010 年间在覆盖内罗毕城市健康和人口监测系统的两个贫民窟中约 72000 名 15-54 岁人群中发生的 2070 人死亡的数据。只有进行了口头尸检的死亡才包括在研究中。我们将分析分为两个时期:“早期”(2003-2006 年),恰逢肯尼亚开始实施 ART 项目,“晚期”(2007-2010 年),恰逢该项目在全国范围内扩大规模。我们按性别和年龄计算了两个时期的每 1000 人年死亡率。使用泊松回归来预测两个时期的 HIV 死亡率风险,同时控制年龄和性别。
总体而言,HIV 死亡率从早期的 2.5/1000 人年显著下降到晚期的 1.7/1000 人年。在控制年龄和性别后,晚期死于 HIV 的风险比早期低 53%。与男性相比,女性在两个时期的 HIV 死亡率下降幅度更大。与此同时,两个时期之间非 HIV 死亡率的风险没有显著变化。
内罗毕贫民区的人群 HIV 死亡率在与肯尼亚扩大 ART 供应大致同期显著降低。然而,需要进一步的研究,将 ART 覆盖数据纳入死亡率估计中。这种信息将增强我们对 ART 扩大规模在降低肯尼亚边缘化贫民区成年死亡率方面的全面影响的理解。